NasdaqGS - Delayed Quote USD
Amgen Inc. (AMGN)
279.84
+1.94
+(0.70%)
At close: 4:00:01 PM EDT
280.00
+0.16
+(0.06%)
After hours: 6:49:40 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 304,009 | 19 |
| Sales | 80,076 | 6 |
| Net Shares Purchased (Sold) | 223,933 | 25 |
| Total Insider Shares Held | 1.17M | -- |
| % Net Shares Purchased (Sold) | 23.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BUSCH MATTHEW C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GRAHAM JONATHAN P General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| SANTOS ESTEBAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GORDON MURDO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| REESE DAVID M. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GRIFFITH PETER H. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GRYGIEL NANCY A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| KHOSLA RACHNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| MILLER DEREK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| BRADWAY ROBERT A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| REESE DAVID M. Chief Technology Officer | Sale at price 293.22 - 304.44 per share. | Direct | 10,233,748 | Feb 21, 2025 |
| MILLER DEREK Officer | Sale at price 292.56 - 293.74 per share. | Direct | 593,934 | Feb 19, 2025 |
| SANTOS ESTEBAN Officer | Sale at price 292.84 per share. | Direct | 2,550,903 | Feb 19, 2025 |
| SANTOS ESTEBAN Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 1,361,965 | Feb 19, 2025 |
| REESE DAVID M. Chief Technology Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 1,361,965 | Feb 19, 2025 |
| MILLER DEREK Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 238,277 | Feb 19, 2025 |
| GORDON MURDO Officer | Sale at price 294.79 per share. | Direct | 2,585,644 | Feb 11, 2025 |
| GRAHAM JONATHAN P General Counsel | Sale at price 293.12 per share. | Direct | 7,341,123 | Feb 7, 2025 |
| GRAHAM JONATHAN P General Counsel | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 3,915,786 | Feb 7, 2025 |
| GRYGIEL NANCY A Officer | Sale at price 304.47 per share. | Direct | 483,808 | Feb 5, 2025 |
| GRAHAM JONATHAN P General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 5, 2024 |
| BRADWAY ROBERT A Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 2, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
| HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
| HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| KLOTMAN MARY E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| JACKS TYLER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| GARLAND GREGORY C. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| MILES AMY E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| ECKERT ROBERT ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| KULLMAN ELLEN JAMISON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| AUSTIN WANDA M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| DRUKER BRIAN J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| BRADNER JAMES E. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| BUSCH MATTHEW C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| GRAHAM JONATHAN P General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| SANTOS ESTEBAN Officer | Stock Award(Grant) at price 300.30 per share. | Direct | 899,999 | May 7, 2024 |
| GORDON MURDO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| REESE DAVID M. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| GRIFFITH PETER H. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| GRYGIEL NANCY A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
Related Tickers
ABBV AbbVie Inc.
180.37
+1.88%
MRK Merck & Co., Inc.
79.84
+1.40%
BMY Bristol-Myers Squibb Company
48.69
+0.33%
GILD Gilead Sciences, Inc.
106.15
-0.22%
JNJ Johnson & Johnson
154.93
-0.29%
BIIB Biogen Inc.
119.51
+1.13%
PFE Pfizer Inc.
22.78
+1.74%
NVS Novartis AG
111.17
+0.94%
NVO Novo Nordisk A/S
62.63
+2.17%
LLY Eli Lilly and Company
859.73
+3.65%